Sonic Healthcare Limited (ASX: SHL) - Share Price
Current share price for SHL : $20.090 0.04 (0.20%)+
Sonic Healthcare (SHL), an ASX-listed company, is involved in provision of medical diagnostic services and the provision of administrative services and facilities to medical practitioners.
SHL General Information +
| ASX Code | SHL |
| Website | N/A |
| Industry/Sector | Health Care Services |
| Market Cap ($M) | 9,909 |
| SHL Share Price | $20.050 |
| Day High | $20.125 |
| Day Low | $19.820 |
| Last Close | $20.050 |
| SHL Share Price Movement | - ( No change ) |
Prices as at 10:36, 22 Jun 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
Sonic Healthcare Limited (SHL) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|---|---|---|---|---|---|---|
| Result | 45¢ | 60% | 4 Mar 2026 | 19 Mar 2026 | - | - | - |
| HFResult | 63¢ | 35% | 3 Sep 2025 | 18 Sep 2025 | - | - | - |
| Result | 44¢ | 0% | 5 Mar 2025 | 20 Mar 2025 | - | - | - |
See all dividends from Sonic Healthcare Limited (SHL) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Sonic Healthcare Limited (SHL) price-sensitive announcements
SHL - CEO Presentation Half Year Results to 31 December 2025
Sonic Healthcare Limited reported its half-year results for the period ending 31 December
Sonic Healthcare Limited (SHL)
19 Feb 2026 | 8:50 AM
19 Feb 2026 | 8:50 AM
SHL - Media Release Half Year Results to 31 December 2025
Sonic Healthcare Limited reported a strong financial performance for the half-year ended 3
Sonic Healthcare Limited (SHL)
19 Feb 2026 | 8:49 AM
19 Feb 2026 | 8:49 AM
SHL - Half Yearly Report and Accounts
Sonic Healthcare Limited's half-year report for the period ending 31 December 2025 reveals
Sonic Healthcare Limited (SHL)
19 Feb 2026 | 8:42 AM
19 Feb 2026 | 8:42 AM
SHL - 2025 AGM CEO Presentations and Proxy Summary
During the 2025 Annual General Meeting, Sonic Healthcare Limited detailed its financial pe
Sonic Healthcare Limited (SHL)
20 Nov 2025 | 8:59 AM
20 Nov 2025 | 8:59 AM
Sonic Healthcare Limited (SHL) Recent ASX Announcements
SHL Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2026F | $601.94 | $119.00 | 18.50% | 23.88 | 109.00 | 3.84% | 30.0% |
| 2025F | $507.92 | $100.41 | -1.70% | 28.30 | 108.00 | 3.80% | 30.0% |
| 2024A | $487.02 | $102.10 | -29.60% | 29.37 | 106.00 | 3.54% | 0.0% |
SHL Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2024 A | 2025 F | 2026 F | 2024 A | 2025 F | 2026 F | 2024 A | 2025 F | 2026 F | ||
| Australian Clinical Labs Limited (ACL) | $408M | -0.0336 | -0.0547 | 0.2436 | 12.0928 | 12.7921 | 10.2865 | 5.71% | 5.02% | 6.39% |
| Healius Limited (HLS) | $283M | -4.7068 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 1.54% |
| Integral Diagnostics Limited (IDX) | $757M | -1.3095 | 0.6319 | 0.2032 | 26.5013 | 16.2400 | 13.4973 | 3.20% | 3.94% | 4.60% |
| Sonic Healthcare Limited (SHL) | $9,806M | 0.0625 | 0.1134 | 0.1484 | 18.5942 | 16.7003 | 14.5423 | 5.39% | 5.52% | 5.57% |
SHL Directors
| Name | Position | Start Date |
|---|---|---|
| Mr Christopher David Wilks | Chief Financial Officer, Finance Director | 5 Dec 1989 |
| Mr Neville Mitchell | Non-Executive Director | 29 Sep 2017 |
| Professor Suzanne Crowe | Non-Executive Director | 6 Apr 2020 |
| Professor Christine Constance Bennett | Non-Executive Director | 26 Sep 2022 |
| Ms Kathryn (Kate) Dianne Spargo | Non-Executive Director | 1 Jul 2010 |
| Ms Nicola Wakefield Evans | Non-Executive Director | 10 Feb 2025 |
| Dr Katharine Giles | Non-Executive Director | 26 Sep 2022 |
| Mr James Pacey Newcombe | Non-Executive Director | 20 Nov 2025 |
| Mr Mark Raymond Compton | Non-Executive Director, Non-Executive Chairman | 7 Oct 2014 |
Sonic Healthcare Limited (SHL) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 16 Oct 2025 | WAKEFIELD EVANS, Nicola | Buy | Indirect Shares | 2,500 | $21.780 | $54,450.000 |
| 15 Oct 2025 | GILES, Katharine | Buy | Indirect Shares | 1,000 | $21.169 | $21,169.200 |
| 3 Oct 2025 | GILES, Katharine | Buy | Indirect Shares | 1,000 | $21.720 | $21,720.000 |
See all changes in directors' interest & trades for Sonic Healthcare Limited (SHL) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
SHL Management
| Name | Position |
|---|---|
| Paul Joseph Alexander | Company Secretary,Deputy Chief Financial Officer |
SHL Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Sonic Healthcare Limited (SHL). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 35,419,922 (7.17%) | State Street Corporation and subsidiaries |
| 34,297,014 (6.94%) | BlackRock Group |
| 28,857,614 (5.84%) | The Vanguard Group,Inc |
SHL Calendar of Events
| Date | Event |
|---|---|
| 18 February 2027 | Report (Interim) |
| 23 September 2026 | Report (Annual) |
| 20 August 2026 | Report (Prelim) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
